Renol Polychem Board of Directors

Get the latest insights into the leadership at Renol Polychem. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Bhaveshbhai Mansukhbhai Harsoda Managing Director
Mr. Naitik Bhaveshbhai Harsoda Director
Ms. Anjali Hukambhai Jeshani Non Exe.Non Ind.Director
Mr. Anandbhai Nalinbhai Pathak Independent Director
Ms. Nikita Gaurav Tank Independent Director

Renol Polychem Share price

RNPL

71

2.10 (-2.87%)
NSE
BSE
Last updated on 4 Sep, 2025 | 13:24 IST
BUYSELL
Today's High

73.10

Today's Low

69.50

52 Week Low

69.00

52 Week High

105.00

The current prices are delayed, login to your account for live prices

Renol Polychem FAQs

The board at Renol Polychem consists of experienced professionals, including Mr. Bhaveshbhai Mansukhbhai Harsoda , Mr. Naitik Bhaveshbhai Harsoda , and others, overseeing the company’s strategic and corporate governance.

Directors at Renol Polychem are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Bhaveshbhai Mansukhbhai Harsoda is the current chairman at Renol Polychem.

Executive directors at Renol Polychem are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Renol Polychem adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Renol Polychem, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.